Studies have focused on breast cancer, non-small cell lung cancer and squamous cell carcinoma of the head and neck, and there are indications that BAG-1 expression may also be altered in glioblastoma, cervical cancer and haemopoietic malignancies (Table 2). This evidence concerns the gene BAG1 and cervical carcinoma.